Stoneridge Investment Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,829
| Closed | -$635K | – | 128 |
|
|
2020
Q2 | $635K | Sell |
1,829
-394
| -18% | -$137K | 0.27% | 86 |
|
|
2020
Q1 | $595K | Hold |
2,223
| – | – | 0.27% | 79 |
|
|
2019
Q4 | $720K | Sell |
2,223
-53
| -2% | -$17.2K | 0.24% | 102 |
|
|
2019
Q3 | $622K | Sell |
2,276
-149
| -6% | -$40.7K | 0.23% | 104 |
|
|
2019
Q2 | $1.29M | Buy |
+2,425
| New | +$1.29M | 0.46% | 74 |
|
|
2017
Q4 | – | Sell |
-720
| Closed | -$259K | – | 247 |
|
|
2017
Q3 | $259K | Sell |
720
-2,804
| -80% | -$1.01M | 0.04% | 191 |
|
|
2017
Q2 | $1.03M | Buy |
+3,524
| New | +$1.03M | 0.15% | 113 |
|
|
2017
Q1 | – | Sell |
-3,156
| Closed | -$581K | – | 337 |
|
|
2016
Q4 | $581K | Buy |
+3,156
| New | +$581K | 0.08% | 215 |
|
|
2014
Q1 | – | Sell |
-6,506
| Closed | -$1.11M | – | 219 |
|
|
2013
Q4 | $1.11M | Buy |
6,506
+1,203
| +23% | +$205K | 0.21% | 85 |
|
|
2013
Q3 | $831K | Buy |
5,303
+1,080
| +26% | +$169K | 0.18% | 95 |
|
|
2013
Q2 | $732K | Buy |
+4,223
| New | +$732K | 0.17% | 91 |
|